154 related articles for article (PubMed ID: 20738210)
1. Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing.
da Silva L; Carvalho E; Cruz MT
Expert Opin Biol Ther; 2010 Oct; 10(10):1427-39. PubMed ID: 20738210
[TBL] [Abstract][Full Text] [Related]
2. Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing.
Pradhan Nabzdyk L; Kuchibhotla S; Guthrie P; Chun M; Auster ME; Nabzdyk C; Deso S; Andersen N; Gnardellis C; LoGerfo FW; Veves A
J Vasc Surg; 2013 Sep; 58(3):766-75.e12. PubMed ID: 23755976
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and neuropeptides: the connection in diabetic wound healing.
Pradhan L; Nabzdyk C; Andersen ND; LoGerfo FW; Veves A
Expert Rev Mol Med; 2009 Jan; 11():e2. PubMed ID: 19138453
[TBL] [Abstract][Full Text] [Related]
4. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
5. Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.
Leal EC; Carvalho E; Tellechea A; Kafanas A; Tecilazich F; Kearney C; Kuchibhotla S; Auster ME; Kokkotou E; Mooney DJ; LoGerfo FW; Pradhan-Nabzdyk L; Veves A
Am J Pathol; 2015 Jun; 185(6):1638-48. PubMed ID: 25871534
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects.
Krishnan ST; Quattrini C; Jeziorska M; Malik RA; Rayman G
Diabetes Care; 2007 Dec; 30(12):3058-62. PubMed ID: 17898089
[TBL] [Abstract][Full Text] [Related]
7. Autonomic nerve dysfunction and impaired diabetic wound healing: The role of neuropeptides.
Theocharidis G; Veves A
Auton Neurosci; 2020 Jan; 223():102610. PubMed ID: 31790954
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in the development and healing of diabetic foot ulceration.
Dinh T; Tecilazich F; Kafanas A; Doupis J; Gnardellis C; Leal E; Tellechea A; Pradhan L; Lyons TE; Giurini JM; Veves A
Diabetes; 2012 Nov; 61(11):2937-47. PubMed ID: 22688339
[TBL] [Abstract][Full Text] [Related]
9. Inflammasomes in wound healing and fibrosis.
Artlett CM
J Pathol; 2013 Jan; 229(2):157-67. PubMed ID: 23023641
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration.
Vouillarmet J; Maucort-Boulch D; Michon P; Thivolet C
Diabetes Technol Ther; 2013 Jul; 15(7):601-5. PubMed ID: 23631605
[TBL] [Abstract][Full Text] [Related]
11. Vascular and nerve lesions of the diabetic foot--a morphological study.
Popescu RM; Cotuţiu C; Graur M; Căruntu ID
Rom J Morphol Embryol; 2010; 51(3):483-8. PubMed ID: 20809024
[TBL] [Abstract][Full Text] [Related]
12. Mast Cells Regulate Wound Healing in Diabetes.
Tellechea A; Leal EC; Kafanas A; Auster ME; Kuchibhotla S; Ostrovsky Y; Tecilazich F; Baltzis D; Zheng Y; Carvalho E; Zabolotny JM; Weng Z; Petra A; Patel A; Panagiotidou S; Pradhan-Nabzdyk L; Theoharides TC; Veves A
Diabetes; 2016 Jul; 65(7):2006-19. PubMed ID: 27207516
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptides, Inflammation, Biofilms, and diabetic Foot Ulcers.
Yang S; Hu L; Han R; Yang Y
Exp Clin Endocrinol Diabetes; 2022 Jul; 130(7):439-446. PubMed ID: 34225369
[TBL] [Abstract][Full Text] [Related]
14. [Healing of skin lesions in diabetic foot syndrome during hospitalization].
Jirkovská A
Vnitr Lek; 2006 May; 52(5):459-64. PubMed ID: 16771090
[TBL] [Abstract][Full Text] [Related]
15. Monitoring temporal development and healing of diabetic foot ulceration using hyperspectral imaging.
Yudovsky D; Nouvong A; Schomacker K; Pilon L
J Biophotonics; 2011 Aug; 4(7-8):565-76. PubMed ID: 21462349
[TBL] [Abstract][Full Text] [Related]
16. The diabetic foot: pathogenesis and clinical evaluation.
Schaper NC; Nabuurs-Franssen MH
Semin Vasc Med; 2002 May; 2(2):221-8. PubMed ID: 16222613
[TBL] [Abstract][Full Text] [Related]
17. Attack of the NETs! NETosis primes IL-1β-mediated inflammation in diabetic foot ulcers.
Lee MKS; Sreejit G; Nagareddy PR; Murphy AJ
Clin Sci (Lond); 2020 Jun; 134(12):1399-1401. PubMed ID: 32556177
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase 1B inhibition as a potential therapeutic target for chronic wounds in diabetes.
Figueiredo A; Leal EC; Carvalho E
Pharmacol Res; 2020 Sep; 159():104977. PubMed ID: 32504834
[TBL] [Abstract][Full Text] [Related]
19. Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes.
Tentolouris N; Voulgari C; Liatis S; Kokkinos A; Eleftheriadou I; Makrilakis K; Marinou K; Katsilambros N
Diabetes Care; 2010 May; 33(5):1112-4. PubMed ID: 20150296
[TBL] [Abstract][Full Text] [Related]
20. Atypical Diabetic Foot Ulcer Keratinocyte Protein Signaling Correlates with Impaired Wound Healing.
Hoke GD; Ramos C; Hoke NN; Crossland MC; Shawler LG; Boykin JV
J Diabetes Res; 2016; 2016():1586927. PubMed ID: 27840833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
